RLX Technology Shares: Can the Recovery Gain Traction?

RLX Technology Inc. shares are presenting a complex picture to investors. The stock concluded Friday’s session at $2.43, marking a 1.25% gain, accompanied by increased trading activity. Despite this upward movement, the broader technical outlook remains uncertain. Market observers are questioning whether the Chinese e-cigarette manufacturer is establishing a sustainable reversal or merely experiencing temporary relief.

Quarterly Performance Provides Foundation

The company’s operational performance offers compelling evidence of growth. For the second quarter of 2025, RLX Technology reported revenue of 879.95 million Chinese yuan (approximately $122.8 million USD). This represents a substantial increase compared to the 627.18 million yuan recorded during the same period last year. The company also registered significant profit expansion that aligned with market expectations.

These strong fundamental metrics demonstrate robust business health, though questions remain about their ability to consistently drive share price appreciation amid broader market concerns.

Conflicting Technical Indicators Create Uncertainty

Friday’s trading session saw RLX shares fluctuate between $2.40 and $2.48, representing a daily trading range of 3.13%. The stock has advanced 4.74% since generating a buy signal from a recent low point on Wednesday.

However, technical analysis reveals conflicting messages:
* Short-term moving averages currently indicate buying opportunities
* Longer-term moving averages continue to suggest selling pressure
* Trading volume reached two million shares, equivalent to roughly $4.77 million

Should investors sell immediately? Or is it worth buying RLX Technology?

This combination of price advancement with heightened trading activity typically suggests positive momentum, yet the contradictory signals between short and long-term indicators have led market experts to maintain a “Hold” rating on the stock.

Analyst Consensus Remains Cautious

Financial experts present a nuanced assessment of RLX Technology’s prospects. While researchers consider the company undervalued relative to its intrinsic worth and project a 32% earnings growth trajectory in coming years, their price targets tell a more restrained story:

• The average 12-month price target among two Wall Street analysts stands at $2.25, implying potential downside of 8.35% from current levels
• The consensus rating is “Hold” with a score of 2.00 points
• This assessment appears more conservative than the broader Consumer Discretionary sector

Several significant risk factors continue to influence valuation:

• Persistent regulatory uncertainty within the electronic vaporizer market
• Prevalence of illicit market operations in China
• Divergent fair value estimates ranging between $3.04 and $3.87 per share

The stock currently navigates competing forces—solid operational performance against cautious analyst positioning and structural industry challenges. While recent upward movement provides optimism, market activity in the coming sessions will determine whether this represents a lasting trend or temporary respite.